HM Payson & Co’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $39K | Hold |
200
| – | – | ﹤0.01% | 756 |
|
|
2026
Q1 | $44.9K | Hold |
200
| – | – | ﹤0.01% | 706 |
|
|
2025
Q4 | $48.2K | Hold |
200
| – | – | ﹤0.01% | 697 |
|
|
2025
Q3 | $54.7K | Hold |
200
| – | – | ﹤0.01% | 670 |
|
|
2025
Q2 | $51.6K | Hold |
200
| – | – | ﹤0.01% | 646 |
|
|
2025
Q1 | $44.8K | Hold |
200
| – | – | ﹤0.01% | 664 |
|
|
2024
Q4 | $45.7K | Sell |
200
-12
| -6% | -$2.89K | ﹤0.01% | 657 |
|
|
2024
Q3 | $51.8K | Buy |
212
+12
| +6% | +$2.68K | ﹤0.01% | 624 |
|
|
2024
Q2 | $38.3K | Hold |
200
| – | – | ﹤0.01% | 644 |
|
|
2024
Q1 | $39.6K | Hold |
200
| – | – | ﹤0.01% | 638 |
|
|
2023
Q4 | $34.4K | Hold |
200
| – | – | ﹤0.01% | 651 |
|
|
2023
Q3 | $29.6K | Hold |
200
| – | – | ﹤0.01% | 675 |
|
|
2023
Q2 | $43.7K | Hold |
200
| – | – | ﹤0.01% | 606 |
|
|
2023
Q1 | $43.8K | Sell |
200
-204
| -50% | -$44.3K | ﹤0.01% | 598 |
|
|
2022
Q4 | $84.1K | Buy |
404
+4
| +1% | +$879 | ﹤0.01% | 487 |
|
|
2022
Q3 | $87K | Hold |
400
| – | – | ﹤0.01% | 489 |
|
|
2022
Q2 | $84K | Hold |
400
| – | – | ﹤0.01% | 497 |
|
|
2022
Q1 | $97K | Hold |
400
| – | – | ﹤0.01% | 498 |
|
|
2021
Q4 | $104K | Hold |
400
| – | – | ﹤0.01% | 492 |
|
|
2021
Q3 | $105K | Hold |
400
| – | – | ﹤0.01% | 469 |
|
|
2021
Q2 | $99K | Hold |
400
| – | – | ﹤0.01% | 484 |
|
|
2021
Q1 | $78K | Hold |
400
| – | – | ﹤0.01% | 525 |
|
|
2020
Q4 | $85K | Hold |
400
| – | – | ﹤0.01% | 501 |
|
|
2020
Q3 | $69K | Buy |
+400
| New | +$73.9K | ﹤0.01% | 504 |
|
|
2020
Q1 | – | Sell |
-2,800
| Closed | -$434K | – | 963 |
|
|
2019
Q4 | $434K | Hold |
2,800
| – | – | 0.01% | 274 |
|
|
2019
Q3 | $378K | Hold |
2,800
| – | – | 0.01% | 292 |
|
|
2019
Q2 | $342K | Buy |
+2,800
| New | +$310K | 0.01% | 309 |
|
|
2018
Q4 | – | Sell |
-2,800
| Closed | -$323K | – | 277 |
|
|
2018
Q3 | $323K | Hold |
2,800
| – | – | 0.01% | 263 |
|
|
2018
Q2 | $290K | Hold |
2,800
| – | – | 0.01% | 283 |
|
|
2018
Q1 | $276K | Hold |
2,800
| – | – | 0.01% | 280 |
|
|
2017
Q4 | $237K | Hold |
2,800
| – | – | 0.01% | 318 |
|
|
2017
Q3 | $215K | Hold |
2,800
| – | – | 0.01% | 303 |
|
|
2017
Q2 | $218K | Hold |
2,800
| – | – | 0.01% | 314 |
|
|
2017
Q1 | $202K | Buy |
+2,800
| New | +$194K | 0.01% | 322 |
|
|
2015
Q2 | – | Sell |
-2,800
| Closed | -$201K | – | 299 |
|
|
2015
Q1 | $201K | Buy |
+2,800
| New | +$182K | 0.01% | 288 |
|
Other funds holding RMD
AT
DJSG
CIM
AC
MPWT
NAM
CNB
HM Payson & Co's RMD Position: Q2 2026 in Review
HM Payson & Co held its ResMed (RMD) position steady in Q2 2026 at 200 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #756.
HM Payson & Co first reported a position in RMD in Q1 2015 and has held it in 35 quarters since. The position peaked at $434K in Q4 2019. 141 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- HM Payson & Co held 200 shares of ResMed worth $39K as of Q2 2026.
- HM Payson & Co left its ResMed share count unchanged in Q2 2026.
- ResMed made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #756 holding.
- HM Payson & Co first reported a position in ResMed in Q1 2015 and has held it in 35 quarters since.
- HM Payson & Co's ResMed position peaked at $434K in Q4 2019.
- 141 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.